Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Hepatitis C REPLY

被引：0
|
作者：
Albrecht, Janice [1 ]
McHutchison, John [2 ]
Sulkowski, Mark [3 ]
机构：
[1] Schering Plough Res Inst, Kenilworth, NJ USA
[2] Duke Univ, Durham, NC USA
[3] Johns Hopkins Univ, Baltimore, MD USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 361卷 / 18期
关键词：
TRIAL;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1809 / 1809
页数：1
相关论文
共 50 条
  • [1] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Hepatitis C
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (18): : 1808 - 1809
  • [2] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
    McHutchison, John G.
    Lawitz, Eric J.
    Shiffman, Mitchell L.
    Muir, Andrew J.
    Galler, Greg W.
    McCone, Jonathan
    Nyberg, Lisa M.
    Lee, William M.
    Ghalib, Reem H.
    Schiff, Eugene R.
    Galati, Joseph S.
    Bacon, Bruce R.
    Davis, Mitchell N.
    Mukhopadhyay, Pabak
    Koury, Kenneth
    Noviello, Stephanie
    Pedicone, Lisa D.
    Brass, Clifford A.
    Albrecht, Janice K.
    Sulkowski, Mark S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (06): : 580 - 593
  • [3] Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin
    Rustgi, V. K.
    Esposito, S.
    Hamzeh, F. M.
    Shiffman, M. L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (05) : 433 - 440
  • [4] The effect of weight on exposure in hepatitis C: Peginterferon alfa-2b and peginterferon alfa-2a
    Silva, M
    Cutler, D
    Poo-Ramirez, JL
    Wagner, F
    Jackson, M
    Cullen, C
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A723 - A723
  • [5] Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain
    Turnes, Juan
    Romero-Gomez, Manuel
    Planas, Ramon
    Sola, Ricard
    Garcia-Samaniego, Javier
    Diago, Moises
    Crespo, Javier
    Calleja, Jose Luis
    Rubio-Terres, Carlos
    Ventayol, Pere
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2013, 36 (09): : 555 - 564
  • [6] Clinical and persistency outcomes in hepatitis C patients treated with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin
    Hassanein, T. I.
    Ye, X.
    Blumentals, W. A.
    Brixner, D. I.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S295 - S296
  • [7] Responses to peginterferon alfa-2a versus alfa-2b plus ribavirin in a Mexican population with chronic hepatitis C
    Sandoval, J.
    Mata, J.
    Gaytan, J.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2013, 20 : 25 - 25
  • [8] Responses to peginterferon alfa-2a vs alfa-2b plus ribavirin in a Mexican population with chronic hepatitis C
    Luis Sandoval-Ramirez, Jorge
    Antonio Mata-Marin, Jose
    Huerta-Garcia, Gloria
    Enrique Gaytan-Martinez, Jesus
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2015, 9 (03): : 267 - 273
  • [9] Peginterferon alfa-2b plus ribavirin for chronic hepatitis - Reply
    Manns, MP
    McHutchison, J
    Koury, K
    Albrecht, JK
    [J]. LANCET, 2002, 359 (9302): : 264 - 264
  • [10] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C - Reply
    Fried, MW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03): : 260 - 260
12345